Results 121 to 130 of about 8,232,099 (206)

Next‐Generation Brain Health Monitoring Enabled by Integrated Wearable AI Infrastructure

open access: yesSmart Medicine, Volume 5, Issue 5, October 2026.
This review presents an integrated framework for next‐generation brain‐health monitoring that connects molecular pathology to digital biomarkers via multimodal wearable sensing, signal processing, and AI‐driven analytics. It highlights advances in sensor design, data quality, edge computing, artificial intelligence, digital twins, and clinical ...
Muhammad Hasan Masrur   +4 more
wiley   +1 more source

Braking Time and Cognitive, Visual, and Motor Determinants in Older Drivers With Type 2 Diabetes Mellitus With and Without Diabetic Peripheral Neuropathy: A Controlled Cross‐Sectional Study

open access: yesJournal of Diabetes, Volume 18, Issue 10, October 2026.
Older drivers with T2DM show significantly longer braking times compared to those without diabetes, regardless of the presence of peripheral neuropathy based on the Michigan Neuropathy Screening Instrument. Female sex and reduced plantar flexor strength predict poorer braking performance.
Vivian Rodrigues de Matos Souza   +5 more
wiley   +1 more source

Exploration of Pyrazole‐Sulfonamide Hybrids: Synthesis, Molecular Modeling, Potential Antimicrobial, DHFR Inhibitor, and Pharmacokinetic Profile

open access: yesChemical Biology &Drug Design, Volume 108, Issue 4, October 2026.
Nine pyrazole‐sulfonamide hybrids 5, 6, and 7 were synthesized and characterized by IR, NMR, and MS. The DFT computations of the built hybrids presented a comparable non‐planar configuration. Comparable HOMO‐LUMO structures were observed, except for the nitro‐derivatives 5c and 6c.
Adhwa A. Alharbi   +7 more
wiley   +1 more source

Bridging gaps in diabetic neuropathy care: A Delphi‐based regional consensus from the Gulf Cooperation Council

open access: yesJournal of Diabetes Investigation, Volume 17, Issue 10, Page 1643-1657, October 2026.
A three‐round Delphi consensus developed GCC‐specific, evidence‐based recommendations for diabetic peripheral neuropathy (DPN) and painful diabetic neuropathy (PND). The consensus emphasizes proactive screening, early multimodal management, and addressing regional barriers to improve early detection, optimize management, and enhance quality of life ...
Abdulrahman Alshaikh   +13 more
wiley   +1 more source

Upcoming therapies for steatotic liver disease: Translating breakthroughs into clinical practice

open access: yesJournal of Internal Medicine, Volume 300, Issue 4, Page 440-460, October 2026.
Abstract Metabolic dysfunction‐associated steatotic liver disease (MASLD) is the most common chronic liver disease worldwide and a leading cause of cirrhosis, hepatocellular carcinoma, and cardiometabolic morbidity. Often clinically silent until advanced fibrosis develops, management has largely relied on lifestyle interventions, with limited ...
Philip N. Newsome, Saima Ajaz
wiley   +1 more source

Scientific basis and applicability of the ISO 2631-1 health guidance caution zone. [PDF]

open access: yesInt Arch Occup Environ Health
Tarabini M   +4 more
europepmc   +1 more source

Prognostic Value of Liver Stiffness in Advanced Chronic Liver Disease After Hepatitis C Virus Eradication

open access: yesLiver International, Volume 46, Issue 10, October 2026.
ABSTRACT Background & Aim Sustained‐virological‐response (SVR) after direct‐acting‐antiviral (DAA) therapy improves outcomes in patients with HCV‐related compensated‐advanced‐chronic‐liver‐disease (cACLD). However, it remains unclear whether absolute post‐SVR LSM or LSM reduction better predicts prognosis after SVR.
Federica Cerini   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy